Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03829501
Recruitment Status : Recruiting
First Posted : February 4, 2019
Last Update Posted : August 14, 2019
Sponsor:
Information provided by (Responsible Party):
Kymab Limited

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2023
  Estimated Study Completion Date : May 2023